Vnitr Lek 2021, 67(3):e08-e10 | DOI: 10.36290/vnl.2021.044

Differential dignosis: "primary" or secondary diabetes - should Cushing´s syndrome be routinely screened in the patients with type 2 diabetes mellitus?

Karolína Melicharová1, Ludmila Brunerová2, Jana Urbanová2, Jan Brož1
1 Interní klinika FN Motol a 2. LF UK, Praha
2 Interní klinika FNKV a 3. LF UK, Praha

Cushing´s syndrome is a rare disease with the population prevalence about 40 patients per 1 million inhabitants, the number among patients with diabetes mellitus (DM) is probably higher. The screening of CS among the DM patients showed the prevalence between 0-2.9% in the groups of outpatients and 2-2.9% among the patients admitted to the hospital at the time of randomization. The routine screening of CS among patients with type 2 DM is not recommended at the moment. Nevertheless, the possibility of CS should be taken into the account mainly in patients with hypertension, obesity, microvascular complications, bad level of metabolic control or high insulin doses, especially, if more of these features are present. A hormonal profile of patients with adrenal incidentaloma should be evaluated.

Keywords: Cushing´s syndrom, diabetes mellitus, screning, adrenal incidentaloma.

Published: May 26, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Melicharová K, Brunerová L, Urbanová J, Brož J. Differential dignosis: "primary" or secondary diabetes - should Cushing´s syndrome be routinely screened in the patients with type 2 diabetes mellitus? Vnitr Lek. 2021;67(3):e08-10. doi: 10.36290/vnl.2021.044.
Download citation

References

  1. Kršek M. Cushingův syndrom. 2013; Interní medicína pro praxi 2013; 15: 368-371.
  2. Lynnette K. Nieman, Beverly M. K. Biller, James W. Findling, John Newell-Price, Martin O. Savage, Paul M. Stewart, Victor M. Montori, The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline, JCEM 2008; 93(5): 1526-1540. https://doi.org/10.1210/jc.2008-0125. Go to original source... Go to PubMed...
  3. Hsieh LB, Mackinney E, Wang TS. When to Intervene for Subclinical Cushing's Syndrome. Surg Clin North Am. 2019; 99(4): 747-758. Go to original source... Go to PubMed...
  4. Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing's syndrome. Lancet. 2015; 386: 913-927. Go to original source... Go to PubMed...
  5. Castinetti F, Morange I, Conte-Devolx B, Brue T. Cushing's disease. Orphanet J Rare Dis. 2012; 7: 41. Go to original source... Go to PubMed...
  6. Rubinstein G, Osswald A, Hoster E et al. Time to Diagnosis in Cushing's Syndrome: A Meta-Analysis Based on 5367 Patients. J Clin Endocrinol Metab. 2020; 105(3): dgz136. Go to original source... Go to PubMed...
  7. Javanmard P, Duan D, Geer EB. Mortality in Patients with Endogenous Cushing's Syndrome. Endocrinol Metab Clin North Am. 2018; 47(2): 313-333. Go to original source... Go to PubMed...
  8. Petramala L, Olmati F, Concistrè A, et al. Cardiovascular and metabolic risk factors in patients with subclinical Cushing [published online ahead of print, 2020 Apr 16]. Endocrine. 2020;10.1007/s12020-020-02297-2. doi:10.1007/s12020-020-02297-2. Go to original source... Go to PubMed...
  9. Barbot M, Ceccato F, Scaroni C. Diabetes Mellitus Secondary to Cushing's Disease. Front Endocrinol (Lausanne). 2018; 9: 284. Go to original source... Go to PubMed...
  10. Kršek M. Poruchy metabolizmu cukrů u Cushingova syndromu. Forum Diabetologicum. 2014; 3: 123-127.
  11. Cansu GB, Atilgan S, Balci MK et al. Which type 2 diabetes mellitus patients should be screened for subclinical Cushing's syndrome? Hormones (Athens). 2017; 16: 22-32. Go to original source... Go to PubMed...
  12. Chiodini I, Torlontano M, Scillitani A et al. Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. Eur J Endocrinol. 2005; 153: 837-844. Go to original source... Go to PubMed...
  13. Gungunes A, Sahin M, Demirci T et al. Cushing's syndrome in type 2 diabetes patients with poor glycemic control. Endocrine. 2014; 47: 895-900. Go to original source... Go to PubMed...
  14. Reimondo G, Castellano E, Grosso M et al. Adrenal Incidentalomas are Tied to Increased Risk of Diabetes: Findings from a Prospective Study. J Clin Endocrinol Metab. 2020; 105(4): dgz284. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.